Paul Singer Advisory Board
By Gil Tanenbaum On Sunday, January 15th, 2017

Paul Singer Takes 8.3 Percent Stake in Health Care Technology and Consulting Company Advisory Board

Activist investor Paul Singer has acquired an 8.3 percent take in the health care technology and consulting company Advisory Board. The acquisition was made through Singer’s Elliott Management. It amounts More...

By Jewish Business News On Wednesday, November 16th, 2016

Bill Ackman Is Looking to Rebound in 2017

  Bill Ackman still aspires to be the next Warren Buffet. This in spite of the brutal loses his Pershing Square Capital suffered in 2016. 2016 was a tough year for Bill Ackman. In addition to his financial More...

By Gil Tanenbaum On Wednesday, November 16th, 2016

Carl Icahn Takes a Bath on Allergan and Federal-Mogul

  Carl Icahn, one of the world’s biggest activist investors, is having trouble with two of his recent positions. The first is in Allergan and the second is in auto parts maker Federal-Mogul. According More...

By Niva Goldberg On Sunday, July 17th, 2016

Ackman vs. Icahn: Bad Year for Wall Street’s Golden Boy

  Four years after the Wall Street fight between two billionaire investors over Herbalife, Bill Ackman marks a bad year. Not only Valeant Phrmacutical steep losses of $1 billion to Pershing Square hedge More...

By News Brief On Wednesday, May 11th, 2016

Bill Ackman Selling Zoetis, but Other Firms Jumping In

Bill Ackman is said to be preparing to partially withdraw from pet health care company Zoetis where he had waged an activist campaign, but first-quarter portfolios rolling in this month already show several other More...

By News Brief On Sunday, May 1st, 2016

Carl Icahn Sells All His Shares Over China Woes, Makes $2 Billion

    It has been a tough week for Apple since the tech company revealed its first quarterly revenue decline in 13 years. It is even tougher now that billionaire Carl Icahn has sold all his Apple shares More...

By News Brief On Tuesday, March 1st, 2016

Bill Ackman Loses $321 Million in One Day After Valeant Plunges

Even for the beleaguered shareholders of Valeant Pharmaceuticals International Inc., Monday was an unusually bad day. The company’s biggest owner, investment firm Ruane Cunniff & Goldfarb, lost an estimated More...

By News Brief On Wednesday, January 20th, 2016

Carl Icahn Is Going After AIG Again

Activist investor Carl Icahn took another swing at American International Group AIG 0.12% on Tuesday, saying the only “sensible” option for the insurer was to split up. Tensions have been mounting between More...

By Jewish Business News On Saturday, January 2nd, 2016

Tax Savings Make Bill Ackman Cut His Firm’s Stake in Valeant

    Citing tax reasons, Bill Ackman, the activist investor and a strong defender of Valeant Pharmaceuticals International, has reduced his firm’s stake in the drug company. In a regulatory filing, billionaire More...

By News Brief On Tuesday, September 15th, 2015

Cheniere Energy Moves Up After Carl Icahn Increases Stake

  Shares of Cheniere Energy Inc. (LNG – Snapshot Report) rose almost 3% in after-hours trading on the NYSE yesterday, on the announcement that activist investor, Carl Icahn, has boosted his stake More...


Delivered by FeedBurner